aTyr Pharma reported $67.58M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Ardelyx USD 381.87M 447K Mar/2026
aTyr Pharma USD 67.58M 178.23M Mar/2026
Biogen USD 9.19B 216.3M Mar/2026
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Curis USD 6.92M 7.5M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
United Therapeutics USD 2.87B 830.5M Mar/2026
Xoma USD 110.71M 5.78M Sep/2025